|
⚲
|
| Keyboard |
| Shiferman Gregory L
✚
|
|
|---|---|
| CIK # | 0002041689 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002041689] | |
| 4 | [0002041689] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Voyager Therapeutics Inc | |
| Shiferman Gregory L | |
| Sage Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Voyager Therapeutics Inc VYGR
Stock Option (Right to Buy) · derivative
|
2026-01-06 | Grant | 100,000 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-07-31 | Tender | 7,215 | ||
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-07-31 | Disposed to issuer | 23,735 | ||
|
Sage Therapeutics Inc SAGE
Stock Option (Right to Buy) · derivative
|
2025-07-31 | Disposed to issuer | 28,000 | ||
|
Sage Therapeutics Inc SAGE
Stock Option (Right to Buy) · derivative
|
2025-07-31 | Disposed to issuer | 10,000 | ||
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-06-24 | Tax withheld | 79 | $9.22 | 728 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-04-10 | Tax withheld | 176 | $6.91 | 1,216 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-04-10 | Grant | 525 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-03-24 | Tax withheld | 79 | $8.21 | 649 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-02-24 | Tax withheld | 2,502 | $7.49 | 18,740 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-02-13 | Tax withheld | 376 | $7.18 | 2,700 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-02-13 | Tax withheld | 251 | $7.18 | 1,802 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2025-01-16 | Grant | 14,000 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Stock Option (Right to buy) · derivative
|
2025-01-16 | Grant | 28,000 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2024-12-24 | Tax withheld | 79 | $5.48 | 433 |
|
Sage Therapeutics Inc SAGE
Common Stock
|
2024-11-01 | Grant | 5,000 | $0.00 | |
|
Sage Therapeutics Inc SAGE
Stock Option (Right to buy) · derivative
|
2024-11-01 | Grant | 10,000 | $0.00 |